Literature DB >> 30985597

Options for the Interpretation of and Recommendations for Acting on Different PROMs in Daily Clinical Practice Using KLIK.

Lotte Haverman1, Hedy A van Oers1, Maud M van Muilekom1, Martha A Grootenhuis1,2.   

Abstract

INTRODUCTION: This paper describes the different ways in which information is being fed back to health care providers (HCPs) using the Dutch evidence-based KLIK Patient-Reported Outcome Measures (PROMs) portal (www.hetklikt.nu). KLIK was initially developed for children with a chronic illness and their parents, and recently expanded for use in adult health care. Patients complete online PROMs at home about their health-related quality of life (HRQOL), symptoms and/or psychosocial functioning before an outpatient consultation with their HCP. PROMs are subsequently converted into an individual KLIK electronic (e)PROfile and discussed during the consultation to facilitate systematic attention for HRQOL. METHODS FOR PRO SCORE
INTERPRETATION: KLIK includes a variety of different PROMs. The KLIK ePROfile initially consisted of literal representations of the individual PROM items in the European traffic light colors (red, orange, green) and only one graph. Over the years, the KLIK ePROfile evolved into a broader spectrum of feedback options; (1) literal representation of individual items, (2) summary scores, and (3) graphic representations (4 options). DEVELOPING RECOMMENDATIONS FOR ACTING ON PRO
RESULTS: The primary goal of KLIK is to longitudinally monitor patient and parent self-reported or proxy-reported health outcomes, which means that the focus of KLIK is not mainly on recommending actions for PRO results. However, there are several aids that help interpretation of the KLIK ePROfile and recommendations are given for actions based on PROM scores. The main aid is the KLIK training, which includes a theoretical and a practical part. In the training, 2 tools-a decision tree and a summary of information about the KLIK ePROfile-are given to the HCPs to assist them in using KLIK. DISCUSSION: Customization of a PROM portal is needed for each different patient group and clinical setting. Because the KLIK website is flexible, every PROM (with good psychometric qualities and permission of the publisher) can be built in. However, implementing and feeding back PROMs in pediatric health care encompasses different challenges, because different versions of the same PROM are needed for children of different ages, as well as proxy and self-report versions.

Entities:  

Mesh:

Year:  2019        PMID: 30985597     DOI: 10.1097/MLR.0000000000001061

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  9 in total

1.  Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review.

Authors:  Yu Ting Chen; Yan Zhi Tan; Mcvin Cheen; Hwee-Lin Wee
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

2.  Effectiveness and cost-effectiveness of a web-based routine assessment with integrated recommendations for action for depression and anxiety (RehaCAT+): protocol for a cluster randomised controlled trial for patients with elevated depressive symptoms in rehabilitation facilities.

Authors:  Johannes Knauer; Yannik Terhorst; Paula Philippi; Selina Kallinger; Sandro Eiler; Reinhold Kilian; Tamara Waldmann; Morten Moshagen; Martina Bader; Harald Baumeister
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

3.  The Use of Patient-Reported Outcome Measures in Daily Clinical Practice of a Pediatric Nephrology Department.

Authors:  Floor Veltkamp; Lorynn Teela; Hedy A van Oers; Lotte Haverman; Antonia H M Bouts
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

4.  Patient-reported outcome measures in pediatric solid organ transplantation: Exploring stakeholder perspectives on clinical implementation through qualitative description.

Authors:  Samantha J Anthony; Katarina Young; Sarah J Pol; Enid K Selkirk; Tom Blydt-Hansen; Suzanne Boucher; Aviva Goldberg; Lorraine Hamiwka; Lotte Haverman; Joanna Mitchell; Simon Urschel; Maria Santana; Jennifer Stinson; Katie Sutherland; Lori J West
Journal:  Qual Life Res       Date:  2021-01-14       Impact factor: 4.147

5.  A retrospective assessment of the KLIK PROM portal implementation using the Consolidated Framework for Implementation Research (CFIR).

Authors:  Hedy A van Oers; Lorynn Teela; Sasja A Schepers; Martha A Grootenhuis; Lotte Haverman
Journal:  Qual Life Res       Date:  2020-08-15       Impact factor: 4.147

6.  SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders.

Authors:  Marjon H Cnossen; Iris van Moort; Simone H Reitsma; Moniek P M de Maat; Roger E G Schutgens; Rolf T Urbanus; Hester F Lingsma; Ron A A Mathot; Samantha C Gouw; Karina Meijer; Annelien L Bredenoord; Rieke van der Graaf; Karin Fijnvandraat; Alexander B Meijer; Emile van den Akker; Ruben Bierings; Jeroen C J Eikenboom; Maartje van den Biggelaar; Masja de Haas; Jan Voorberg; Frank W G Leebeek
Journal:  J Thromb Haemost       Date:  2022-06-02       Impact factor: 16.036

7.  From statistics to clinics: the visual feedback of PROMIS® CATs.

Authors:  Maud M van Muilekom; Michiel A J Luijten; Hedy A van Oers; Caroline B Terwee; Raphaële R L van Litsenburg; Leo D Roorda; Martha A Grootenhuis; Lotte Haverman
Journal:  J Patient Rep Outcomes       Date:  2021-07-10

8.  Clinicians' perspective on the implemented KLIK PROM portal in clinical practice.

Authors:  Lorynn Teela; Maud M van Muilekom; Lieke H Kooij; Anouk W Gathier; Johannes B van Goudoever; Martha A Grootenhuis; Lotte Haverman; Hedy A van Oers
Journal:  Qual Life Res       Date:  2020-05-28       Impact factor: 4.147

9.  Patients' and parents' perspective on the implementation of Patient Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal.

Authors:  Maud M van Muilekom; Lorynn Teela; Hedy A van Oers; Johannes B van Goudoever; Martha A Grootenhuis; Lotte Haverman
Journal:  Qual Life Res       Date:  2021-07-29       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.